Home / Ibritumomab Tiuxetan (90Y) / Italy
IT ATC V10XX02 · updated 2 Nov 2026
Ibritumomab Tiuxetan (90Y) shortage in Italy
Is there an Ibritumomab Tiuxetan (90Y) shortage in Italy?
Yes. As of 2 Nov 2026, 1 Ibritumomab Tiuxetan (90Y) product is reported short in Italy, the first since 1 Jun 2020. No return date has been given. Main reason: manufacturing problem.
Also short in Canada. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | ZEVALIN | CEFT BIOPHARMA S.R.O. | 1 Jun 2020 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.